United States · Markets & Finance · The Motley Fool

Why Viking Therapeutics needs the cash

Published by The Motley Fool · United States 8 h ago

Viking Therapeutics raised $575 million to fund major obesity drug trials, develop its pipeline, and support commercial development of any approvals for VK2735.

Read the full article on The Motley Fool Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.fool.com)

Also worth reading

Business Insider

Meta says it shut down No Kings Instagram account because it thought bots had been unleashed

Fortune

Anthropic commits 5% of its stock to a new ‘public benefit’ fund and may give large donations to traditional nonprofits or to specific populations

CoinDesk

SEC tokenized stock framework faces issuer pushback as Broadcom, Verizon object to OKX-ICE listing

Quartz

10 things first-time cruisers wish they knew before boarding

CNBC

India’s Finance Minister blames easy exits and excess liquidity for equity market's underperformance

OilPrice.com